Pâmela Alegranci Selected Research

botryosphaeran

1/2021	Botryosphaeran Attenuates Tumor Development and the Cancer Cachexia Syndrome in Walker-256 Tumor-Bearing Obese Rats and Improves the Metabolic and Hematological Profiles of These Rats.
12/2020	Botryosphaeran, a (1 → 3)(1 → 6)-β-D-glucan, reduces tumor development and cachexia syndrome in obese male rats by increasing insulin sensitivity and FOXO3a activity.
7/2020	Tumor development in rats and cancer cachexia are reduced by treatment with botryosphaeran by increasing apoptosis and improving the metabolic profile.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pâmela Alegranci Research Topics

Disease

3	Cachexia 01/2021 - 07/2020
3	Neoplasms (Cancer) 01/2021 - 07/2020
2	Obesity 01/2021 - 12/2020
2	Insulin Resistance 01/2021 - 12/2020
2	Macrocytic Anemia 12/2020 - 07/2020
2	Infections 02/2015 - 01/2014
1	Hyperglycemia 01/2021
1	Body Weight (Weight, Body) 12/2020
1	Inflammation (Inflammations) 02/2015
1	Sporotrichosis 02/2015

Drug/Important Bio-Agent (IBA)

3	botryosphaeranIBA 01/2021 - 07/2020
2	SugarsIBA 01/2021 - 12/2020
2	Proteins (Proteins, Gene)FDA Link 12/2020 - 07/2020
2	Biological ProductsIBA 12/2020 - 07/2020
2	Interleukin-17 (Interleukin 17)IBA 02/2015 - 01/2014
1	CholesterolIBA 01/2021
1	HDL CholesterolIBA 07/2020
1	Glucose (Dextrose)FDA LinkGeneric 07/2020
1	LipidsIBA 07/2020
1	Triglycerides (Triacylglycerol)IBA 07/2020
1	InflammasomesIBA 02/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2015
1	CytokinesIBA 02/2015
1	NLR ProteinsIBA 02/2015
1	Interleukin-18 (Interleukin 18)IBA 02/2015
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	Interleukin-12 (IL 12)IBA 01/2014